Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

I tried anti-obesity medication and these were the surprising side-effects' - When Henry Conway hit his forties his BMI became dangerously high. After a lover said ‘I love your little dad bod’, he ...

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence ...

The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s. Congress is also considering such a move.

About 25% of Americans have a health insurance plan that covers these weight loss drugs, according to the AXIACI Obesity Coverage Nexus, a database produced by the Leverage consulting firm.

Medicare, by statute, is still prohibited from paying for the use of obesity medications — a policy that is discriminatory and a reflection of the stigmatization of obesity. The popular focus on ...

In a world grappling with obesity and chronic disease, GLP-1 drugs like Ozempic are emerging as transformative game-changers.